Skip to content

Author

N. Abdulameer

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

374. Intranasal esketamine in treatment-resistant bipolar depression maintained on long-acting aripiprazole

Abstract Background Esketamine intranasal spray is FDA-approved for treatment-resistant depression (TRD), but it is not licensed for use in bipolar disorder due to the risk of antidepressants inducing manic or hypomanic episodes. To date, there is limited data on the use of intranasal esketamine in bipolar disorder, an...

S. Makhoul, N. Abdulameer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.